The Cardiovascular and Hemodynamic Effects of Erythropoietin in Chronic Renal Failure

Journal of Association of Physicians of India

Volumn 48, Issue 3, 2000, Pages 301-306

  Singh, N P ^b   Chandrashekhar, ^b   Nair, M ^a   Anuradha, S ^b   Kohli, R ^b   Agarwal, S K ^b  

^a G B PANT HOSPITAL   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANEMIA; ECHOCARDIOGRAPHY; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 0034158318     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wing AJ, Brunner FP, Brynger H, et al. Cardiovascular - Related causes of death and the fate of patients with renovascular disease. Contrib Nephrol 1984; 41 : 306-11.
2. Fassbinder W, Brunner FP, Brynger H, et al. Combined report on regular dialysis and transplantation in Europe XX, 1989. Nephrol Dial Transplant 1991; 6 (Suppl 1) : 5-35.
3. Harnett JD, Parfrey PS, Griffith SM, et al. Left ventricular hypertrophy in end stage renal disease. Nephron 1988; 48 : 107-15.
4. Silberberg JS, Barre PE, Prichard SS, et al. Impact of left ventricular hypertrophy on survival in end stage renal disease. Kidney Int 1989; 36 : 286-90.
5. Silberberg JS, Rahal DP, Patton DR, et al. Role of anemia in the pathogenesis of LVH in ESRD. Am J Cardiol 1989; 64 : 222-4.
6. Pascoul J, Teruel JL, Mota JL, et al. Regression of left ventricular hypertrophy after partial correction of anemia with rHu EPO in patients on hemodialysis : a prospective study. Clin Nephrol. 1991; 35 : 280-7.
7. Sahn DJ, De Mora A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography : Result of a survey of ECHO measurement. Circulation 1978; 58 : 1072-83.
8. Foley RN, Parfrey PS, Harnett JD, et al. Uremia related prognostic factors in dialysis patients. A cohort study from the start of dialysis theory. J Am Soc Nephrol 1993; 4 : 346-9.
9. Harnett JD, Foley RN, Kent GM. Cardiac disease and hemotocrit level. Am J Kidney Dis 1995; 25 : 53-7.
10. NKF - DOQI Clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30 Suppl 3: S192-237.
11. London GM, Marchais SJ, Guerin AP, et al. Cardiac hypertrophy and arterial alterations in ESRD : Hemodynamic factors. Kidney Int 1993; 43 (Suppl 41) : S42-9.
12. Portoles J, Torralbo A, Martin P, et al. Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 1997; 29 : 541-8.
13. Cannella G, Canna L, Sandrini M, et al. Reversal of left ventricular hypertrophy following rHu EPO treatment of anaemic dialysed uremic patients. Nephrol Dial Transplant 1991; 6: 31-7.
14. Satoh K, Masuda T, Ikeda J, et al. Hemodynamic change by EPO therapy in hemodialysed patients. Hypertension 1990; 15 : 262-6.
15. Wizeman V, Schafer R, Kramer W. Follow up of cardiac changes induced by anaemic compensation in normotensive hemodialysis patients with left ventricular hypertrophy. Nephron 1993; 64 : 202-6.
16. Schwartz AB, Prior JE, Mintz GS, et al. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant human erythropoietin. Transpl Proc 1991; 23 : 1827-30.
17. Radermacher J, Koch KM. Treatment of renal anemia by erythropoietin substitution. The effects on cardiovascular system. Clin Nephrol 1995; 44 : 556-60.
18. Goldberg N, Lundin AP, Delano B, et al. Changes in left ventricular size, wall thickness and function in anaemic patients treated with recombinant human erythropoietin. Am Heart J 1992; 124: 424-7.
19. Muirhead N, Baigman J, Burgess E, et al. Evidence based recommendations for the clinical use of rHu EPO. Am J Kidney Dis 1995; 42 (Suppl 2) : S1-24.
20. Neusser M, Tepel M, Zidek W. Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells. Cardiovasc Res 1993; 27 : 1233-6.